Stable characteristics of intrapopulation heterogeneity in virus-specific Th1 cells during chronic viral challenge infection
Valerie PlajeriD, Adrian Madrigal-AvilésiD, Maria R. DzamukovaiD, Nayar Durán-HernándeziD, Philippe SaikaliiD, Vivien Holecska, Isabel Panse, Katrin LehmanniD, Jinfang ZhuiD, Mir-Farzin MashreghiiD, Ahmed N. HegazyiD, Caroline PeineiD, Max LöhningiD
Abstract
Virus-specific CD4+ T cells typically undergo T helper (Th) 1 differentiation and contribute to a type 1 immune response in infection with lymphocytic choriomeningitis virus (LCMV). Using this model pathogen, we performed an in-depth analysis of the quantitative expression stability of the Th1 key transcription factor T-bet. Previously, it was shown that virus-specific Th1 cells arising in acute infections expressed T-bet at distinct intensities and maintained their T-bet expression differences after viral clearance as memory cells for weeks in the steady state. However, it was unclear whether differential T-bet expression was associated with heterogeneity inside the Th1 population and if the quantitative T-bet memory, particularly of those cells expressing T-bet at low levels, could withhold the strong and continuous stimulation present during chronic infection. Using T-bet-ZsGreen reporter mice, virus-specific Th1 cells were characterized phenotypically at protein, RNA, and DNA/chromatin accessibility levels. The Th1 cells arising during acute LCMV Armstrong infection showed a continuous spectrum of T-bet expression, ranging from cells with very high T-bet to cells with low T-bet. Even though the cells with low T-bet expression clearly possessed Th1 characteristics, they additionally showed certain Tfh-like features at protein and RNA level. When virus-specific Th1 cells were sorted according to T-bet-ZsGreen reporter expression intensity, adoptively transferred, and rechallenged by infecting the host animals with the chronic Clone 13 strain of LCMV, they maintained quantitative differences in T-bet reporter and IFN-{gamma} expression levels. A subpopulation of the progeny of the former T-betlow cells still showed a mild Tfh-associated phenotype. Independent of their past and present T-bet expression level, all virus-reactive CD4+ T cells acquired phenotypic signs of exhaustion as characterized by upregulation of PD-1, LAG3, and TOX and vast absence of effector cytokine co-expression in the chronic infection environment. Collectively, our findings highlight the heterogeneity of T-bet+ antiviral CD4+ T cells and the stability of quantitative differences in individual virus-specific CD4+ T cells during chronic viral challenge infection.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- FWCI
- 0.00
- Field percentile
- 42th percentile
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Delineating the transcriptional landscape and clonal diversity of virus- specific CD4 + T cells during chronic viral infection
- Profiling virus-specific Tcf1+ T cell repertoires during acute and chronic viral infection
A. Yermanos, I. Sandu, … A. Oxenius·bioRxiv·Mar 20, 2020
- Time-resolved systems analysis reveals a critical role of XCR1+ 1 dendritic cells in the maintenance of effector T cells during chronic viral infection
J. Argilaguet, M. Pedragosa, … A. Meyerhans·bioRxiv·Nov 22, 2018
- Opposing effects of T cell receptor signal strength on CD4 T cells responding to acute versus chronic viral infection
M. Künzli, P. Reuther, … C. G. King·bioRxiv·Aug 6, 2020
- Inhibitory IL-10-producing CD4+ T cells develop in a T-bet-dependent manner and facilitate cytomegalovirus persistence via coexpression of arginase-1
M. Clement, K. Ladell, … I. Humphreys·eLifePeer-reviewed·Jul 13, 2023
- Heterogeneity of HCMV-Specific CD8+ T Cells is Established Early in Infection, Clonally Encoded, and Stable Over Time
Samuel D. Klebanoff, Matthew F. Lawrance, … Daniel Campbell·bioRxiv·Oct 16, 2026